This Company is Poised for Explosive Growth in the Booming Market of Air Quality for Food Security and Pathogen Elimination…

Introducing: Applied UV, Inc. (NASDAQ: AUVI), a fully integrated engineering, sales, and marketing company commercializing a suite of solutions focused on utilizing artificial intelligence for infection prevention, air quality and food preservation.

As a provider of clean and effective environmental solutions, the Company could benefit from several key secular drivers longer term. Specifically, the growing focus on indoor air quality across many settings and demand for data-driven disinfection technologies to help drive growth across the portfolio.

Download Research Report

Learn More about Applied UV, Inc. by gaining access to the latest research report

    Thanks for subscribing!
    Check your email for a confirmation message.

    Recent developments include the transformative acquisitions of PURO Lighting and LED Supply Co. PURO Lighting and LED Supply Co. own a powerful suite of products used in education, government, and healthcare that incorporates UV Lighting and a HVAC monitoring software platform; LED Supply Co. provides design, distribution, and implementation services for lighting, controls and smart building technologies.

    With its established strategic manufacturing partnerships and alliances including Canon, Acuity, Johnson Controls, USHIO, Siemens, Grainger, and a global network of 89 dealers and distributors in 52 countries, 47 manufacturing representatives, and 19 US based internal sales representatives, AUVI offers a complete suite of products through its four wholly owned subsidiaries - SteriLumen, MunnWorks, PURO Lighting, and LED Supply Co.

    Strong Growth Potential

    With a global distribution footprint spanning 89 dealers and distributors across 52 countries, Applied UV is well-positioned for continued success. 

    They are forecasting strong revenue growth, with an estimated revenue of approximately $45-50 million in 2023, up from $20.1 million in 2022..

    In a highly fragmented and competitive industry, Applied UV stands out from the crowd with its diversified product portfolio from SteriLumen and MunnWorks that serve across multiple verticals. 

    Applied UV has demonstrated remarkable growth through six strategic acquisitions within a span of 18 months. Their industry-leading technology is revolutionizing the preservation of produce by significantly extending its shelf life. 

    With their best-in-class air and surface disinfection platform, Applied UV is driving improvements in Indoor Air Quality (IAQ) across multiple verticals. Their strategic manufacturing partnership with Canon Virginia Inc., and the recent inclusion of Canon Financial Services Inc., further enhances their capabilities.

    Since the onset of the Covid-19 pandemic, there has been a notable surge in the UV Disinfection and the air purification markets. This growth can be attributed to the increasing need for air purification and disinfection technologies across a wide range of industries, such as healthcare, schools, commercial buildings, correctional facilities, and numerous others.

    By 2026, it is projected that the UV Disinfection market will reach a value of $9 billion and the global air purifier market size is predicted to reach USD 22.84 billion by 2030.

    Applied UV, Inc. (NASDAQ: AUVI) is well-positioned as a leader in these booming markets to capture this multi-billion dollar opportunity.

    AUVI’s subsidiary, SteriLumen offers a portfolio of technologically-advanced, energy efficient air purifier and surface disinfectant systems: Airocide® by Sterilumen, Scientific Air™ by Sterilumen and Lumicide™ by Sterilumen.

    SteriLumen’s patented UV technologies are chosen worldwide by leading companies and organizations for their proprietary patented air purification and disinfection technology to effectively remove respiratory and other infectious viruses, mold, bacteria, allergens and other pathogens.

    Applied UV serves key markets in various sectors, addressing critical challenges and meeting growing demands.

    AUVI has the potential to revolutionize the agricultural industry by combating its annual $400 billion loss caused by crop spoilage. With governments worldwide mandating improvements in air quality, there is a growing demand for innovative air purification technologies that Applied UV provides.

    What sets the Company apart is their alignment with the "clean air" standards introduced by the U.S. Federal EPA in 2022. This positions them as leaders in the industry, offering solutions that meet and exceed regulatory requirements.

    Additionally, AUVI’s focus on tackling the detrimental impact of Hospital Acquired Infections (HAIs) presents a lucrative opportunity. With 1 in 25 patients affected by HAIs and a staggering 3 million infections occurring annually, the need for effective solutions is more critical than ever. 

    By addressing both health concerns and the $270 billion economic impact of HAIs on productivity and absenteeism, Applied UV demonstrates its commitment to making a substantial difference

    Applied UV, Inc. (NASDAQ: AUVI) could be the key to revolutionizing industries, protecting health, and maximizing profits with its cutting-edge solutions!

    Investment Highlights:

    1. Booming Markets: The air purification and UV disinfection markets are experiencing significant growth due to the rise in infectious diseases and the Covid-19 pandemic. With the global air purification market projected to reach a value of $52.16 billion by 2027 and the UV disinfection market estimated to surpass $9 billion by 2026, Applied UV is well-positioned to capitalize on these growing markets with its innovative solutions.
    2. Expanding Agricultural Market: AUVI addresses the alarming $400 billion annual loss in the agricultural industry caused by crop spoilage, tapping into a significant market with substantial growth potential.
    3. Increasing focus on proven food preservation opportunity with expectations for a major product launch at a large international food conference in October of 2023.
    4. Government Mandates: Governments worldwide are mandating improvements in air quality, creating a favorable regulatory environment and driving the demand for innovative air purification technologies offered by Applied UV.
    5. Addressing Critical Healthcare Challenges: The Company's focus on tackling Hospital Acquired Infections (HAIs) responds to a pressing global concern, with 1 in 25 patients affected and 3 million infections occurring annually. Applied UV's solutions offer a promising way to mitigate the economic impact of HAIs on productivity and absenteeism.
    6. Diversified Revenue Streams: Applied UV serves multiple sectors, including agriculture, healthcare, and compliance with ventilation guidelines, allowing for diversified revenue streams and reducing dependency on a single market.
    7. Innovative Technologies: The Company's cutting-edge solutions leverage advanced UV disinfection technology, offering superior pathogen elimination capabilities and setting the Company apart from competitors.
    8. Scalability and Market Reach: With increasing demand for air purification and disinfection technologies, Applied UV has the potential to scale its operations and expand its market reach globally, unlocking significant growth opportunities.
    9. Strong Economic Value Proposition: Applied UV's comprehensive solutions not only address health and safety concerns but also aim to reduce economic losses associated with crop spoilage, HAIs, and productivity impact, making it an attractive investment for stakeholders.
    10. Strong Management and Strategic Partnerships: Applied UV has assembled a team of industry experts and established strategic partnerships, including product co-development with Nasa, to enhance its capabilities, market presence, and competitive advantage.

    Across multiple verticals, Applied UV, Inc. (NASDAQ: AUVI) has established itself as a global player with international distribution and notable collaborations, including product co-development with NASA.

    In the wake of the global pandemic, the demand for air purification systems and UV disinfection technologies has witnessed an unprecedented surge. The widespread onslaught of infectious diseases has underscored the critical need for effective measures to ensure clean and sanitized environments.

    This has prompted a paradigm shift in prioritizing health and safety. Governments, businesses, and individuals across the globe have become increasingly aware of the importance of proactive measures to prevent the transmission of viruses and bacteria. As a result, the demand for air purification systems equipped with advanced filtration technologies and UV disinfection devices has experienced massive demand.

    The market for air purification and UV disinfection is expected to expand as more sectors recognize the importance of maintaining clean and healthy environments. This includes healthcare facilities, commercial buildings, educational institutions, hospitality establishments, and various public spaces.

    As governments continue to implement stringent health and safety regulations, businesses and individuals will increasingly seek out solutions that ensure clean air and sanitized surfaces. 

    This leads us to Applied UV, who has emerged as a frontrunner in meeting this demand, offering state-of-the-art air purification systems and UV disinfection technologies.

    With their research-backed and clinically-proven solutions, 
    Applied UV, Inc. (NASDAQ: AUVI) has positioned itself as a trusted provider offering state-of-the-art technologies.

    About the Company:

    Applied UV is a provider of proprietary surface and air disinfection technology, specializing in improving Indoor Air Quality (IAQ), LED lighting, and luxury mirrors and commercial furnishings. Their diverse product offerings cater to clients globally in both the commercial and retail sectors.

    With a focus on various industries such as healthcare, hospitality, food preservation, cannabis, education, and wineries, Applied UV has established itself as a reliable solution provider. The company has forged strategic manufacturing partnerships and alliances with reputable organizations including Canon Virginia Inc., Acuity Brands Lighting, Johnson Controls International, Siemens, and W.W. Grainger. Additionally, their global network of 89 dealers and distributors in 52 countries ensures widespread availability of their comprehensive product suite.


    SteriLumen presents a portfolio of cutting-edge and energy-efficient systems for air purification and surface disinfection. 

    Sterilumen offers Airocide® air purifiers, renowned for their development in partnership with NASA and their commitment to protecting Earth. 

    Utilizing patented Photocatalytic Oxidation UV light technology, Airocide air purifiers surpass the effectiveness of HEPA filtration by completely destroying airborne viruses, including COVID, mold, odor, and other bacteria and pathogens. Trusted by global organizations and NASA for safety Airocide, is a Class II Medical Device recognized by the FDA. This green and safe solution eliminates airborne viruses without emissions or harmful byproducts. 

    Scientific Air™

    is engineered to create a safe and healthy environment by effectively sanitizing the air. With its proprietary 3-stage air sanitizer technology, Scientific Air eliminates infections and contaminants around the clock. Trusted by renowned institutions like Baptist Health South Florida, NYC Health + Hospitals, NYU Langone Medical Center, Kaiser Permanente, and many others, this portable and powerful air sanitizer swiftly purifies the air.

    Its digital display provides real-time tracking and reporting of crucial data on in-room airflow and quality. With a green, safe, and energy-efficient HEPA filter, Scientific Air ensures no emissions or ozone.


    by Sterilumen is the ultimate disinfectant system specifically designed for high contamination risk sink and drain areas. Backed by Biosafety Level II and III labs, Lumicide is a proven disinfection solution that effectively eliminates over 99.99% of pathogens on various surfaces. Its impressive track record includes the eradication of pathogens such as SARS-CoV-2 surrogate (OC-43), MRSA, H1N1, Candida Auris (C. auris), C. diff, and E. coli. 

    Notably, in June 2022, Lumicide was installed at Mt Sinai Medical Center Morningside, and an academic paper is expected in Q3 2023 to further validate its efficacy.

    PURO Lighting uses light technology to promote health and wellness within spaces. Today PURO provides a suite of UV disinfection systems that have the ability to disinfect air and surfaces in commercial and industrial spaces. They focus their sales efforts in three primary verticals: Education, Government, and Healthcare.  The acquisition of PURO Lighting adds PUROHealth and PURONet - a powerful suite of products used in education, government, and healthcare that incorporates UV Lighting and a HVAC monitoring software platform.  PURO boasts a strong domestic sales network with reps in 43 states, and distribution in all 50 states.  Their product offerings encompass a range of innovative solutions, including UVC systems for air handling, in-room continuous disinfection using cutting-edge Far-UVC technology, and specialized surface disinfection solutions designed specifically for the healthcare industry.

    The PURONet UV IAQ Disinfection Control System is a groundbreaking solution that combines UV safety, control, and reporting in a single, user-friendly platform. It is the first control system designed specifically for seamless operation of PURO Fixtures within a room, ensuring safe and efficient disinfection cycles while collecting valuable data. With real-time reporting and data collection capabilities, users can monitor key indoor air quality (IAQ) metrics and make informed decisions. The system's future-proof software is cloud compatible, offering flexibility and scalability.

    Applied UV has plans to integrate this IAQ software across its entire range of disinfection products, expanding its capabilities to include AI and machine learning for enhanced performance and effectiveness.

    LED Supply Company, founded in 2009, provides design, distribution, and implementation services for lighting, controls and smart building technologies.  LED Supply Co continues to expand its market reach with a focus on new types of energy efficiency and sustainable technologies. Along with its robust e-commerce component, LED Supply Company has recently taken the next step in revenue growth by repositioning itself as a preferred supplier for not only the latest in LED technologies, but the source for emerging technologies and product categories that the construction and retrofit market need; from electric vehicle charging to smart home technology, emergency and safety equipment, and much more.


    MunnWorks specializes in providing custom-made lighted mirrors, hospitality mirrors, and contract vanities.  As a single-source lighting, controls, and technology provider, MunnWorks offers a comprehensive range of products and solutions that streamline decision-making processes and save time and resources for corporate and construction projects.

    Their offerings include LED lighting, full building lighting control networks, stage and theater lighting, RGBW lighting for interiors and exteriors, EV chargers, light switches and dimmers, smoke and carbon monoxide detectors, bathroom fans and hand dryers, backlit mirrors, smart building panels, and smart door locks.


    With a leadership team that has approximately 60 combined years of experience in the oncology diagnostics sector, this team has a proven track record of successful launch/relaunch strategies.

    Max Munn
    President & Director, Applied UV & CEO, MunnWorks 

    Mr. Munn has held this position at Munn Works for over 20 years. Mr. Munn is also Co-chairman of Dieu Donne Inc., a not-for-profit and a leading, world recognized atelier wherein dimensional, handmade paper is utilized in the making of art. Mr. Munn attended MIT from 1961-1966, majored in chemistry and architecture; and received a Bachelors of Architecture degree. Mr. Munn also attended Columbia University for postgraduate studies from 1966-1968, working toward a Ph.D. in architectural history.

    Mike Riccio
    Chief Financial Officer

    Mr. Riccio joins Applied UV with broad experience in corporate and operational finance, most recently as Chief Financial Officer & Treasurer of Panasonic Corporation of North America, leading the finance organization that supports the principal North American subsidiary of Osaka, Japan-based Panasonic Corporation. Throughout his career at the Panasonic subsidiary, he demonstrated a track record as a results-oriented leader with a strong record of improving financial performance across a variety of sectors, including consumer, systems and solutions, and industry. Working with other executives, Mr. Riccio was part of the team that defined and implemented strategies driving significant growth of Panasonic North America revenue.

    He joined Panasonic in October 1986 from Sealed Air Corporation, where he was the Corporate Accounting Manager. Prior to Sealed Air, Mr. Riccio was a Senior Auditor at CohnReznick. Mr. Riccio is a Certified Public Accountant (CPA) and holds a B.A. in accounting from Rutgers University and an MBA in finance from Rutgers Business School.

    Eugene E. Burleson
    Chairman of the Board

    Eugene E. Burleson is a private investor and was Chairman of PET DRx Corporation from June 2005 to July 1, 2010, and its Chief Executive Officer from October 2008 until its acquisition by VCA Antech in July 2010. Mr. Burleson was a director of HealthMont Inc. from September 2000 until its acquisition by SunLink in October 2003.

    In Summary…

    Applied UV, Inc. (NASDAQ: AUVI) is a fully integrated engineering, sales, and marketing company that provides proprietary, patented solutions for pathogen elimination on air and surfaces across multiple booming industries.

    The Company has a track record of successful acquisitions, with six acquisitions completed within the span of 18 months which demonstrates their strategic growth strategy and the potential for further expansion in the future.

    Forecasting 2023 revenue of approximately ~$45-50M

    SteriLumen's patented UV technologies have gained worldwide recognition and trust, leading to partnerships with notable companies and organizations. This extensive collaboration network has established Applied UV as a global player with international distribution channels.

    Applied UV's best-in-class product air and surface disinfection platform is not limited to a single industry. This diversified portfolio positions the company to capture opportunities across various sectors.

    With a rising demand for air quality due to government mandates, growing health concerns, and the Covid-19 pandemic, Applied UV (NASDAQ: AUVI) has the potential to become a leader in the competitive air purification industry.


    Learn More about Applied UV, Inc.  by gaining access to the latest 
    research report

    Download Report




    SCD Media LLC (d/b/a “Smallcaps Daily”), hereinafter referred to as “Smallcaps Daily,” and their affiliates and control persons (the “Publisher”) are in the business of publishing favorable information and/or advertisements (the “Information”) about the securities of publicly traded companies (each an “Issuer” or collectively the “Issuers”) in exchange for compensation (the “Campaigns”). Persons receiving the Information are referred to as the “Recipients.” The person or entity paying the Publisher for the Campaign is referred to herein as the “Paying Party”. The Paying Party may be an Issuer, an affiliated or non-affiliate shareholder of an Issuer, or another person hired by the Issuer or an affiliate or non-affiliate shareholder of the Issuer. The nature and amount of compensation paid to the Publisher for the Campaign and creating and/or publishing the Information about each Issuer is set forth below under the heading captioned, “Compensation”.

    This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment.

    Nothing on this website should be considered personalized financial advice. Any investments recommended herein should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.


    Smallcaps Daily, its managers, its employees, affiliates, and assigns (collectively the "Publisher") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.


    Release of Liability: through use of this website, viewing or using you agree to hold Smallcaps Daily, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Smallcaps Daily encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the company profiled or is available from public sources and Smallcaps Daily makes no representations, warranties, or guarantees as to the accuracy or completeness of the disclosure by the profiled company. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead, Smallcaps Daily strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Smallcaps Daily’s full disclosure is to be read and fully understood before using Smallcaps Daily's website, or joining Smallcaps Daily's email or text list. From time to time, Smallcaps Daily will disseminate information about a company via website, email, sms, and other points of media. By viewing Smallcaps Daily's website and/or reading Smallcaps Daily's email or text newsletter you are agreeing to this ----> https://Smallcaps All potential percentage gains discussed in any communications are based on calculations from the low to the high of the day. We are engaged in the business of marketing and advertising companies for monetary compensation.  

    If you have questions or concerns about a product you’ve seen in one of our emails, emails, text newsletters or SMS, we encourage you to reach out to that company directly.

    Disclaimer – Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated, and edited by the owner of Smallcaps Daily. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Smallcaps Daily. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Companies with low prices per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold our site, its editors, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and its owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares, we will list the information relevant to the stock and the number of shares here.


    In compliance with section 17(b) of the Securities Act we are disclosing that we have been compensated a fee pursuant to an agreement between Small Caps Daily and Applied UV Inc. Small Caps Daily was hired by Applied UV Inc. for a period beginning May 2023 and ending November 2023 to publicly disseminate information about Applied UV Inc. via website, and email. We were paid two hundred twelve thousand five hundred usd via ACH. Readers are advised to review SEC periodic reports: forms 10Q 10K, form 8K, insider reports, forms 3, 4, 5 schedule 13d. Smallcaps Daily is compliant with the CAN-SPAM Act of 2003. Smallcaps Daily does not offer investment advice or analysis, and Smallcaps Daily further urges you to consult your own independent tax, business, financial, and investment advisors. investing in micro-cap, small-cap, and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. The private securities litigation reform act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events, or performance are not statements of historical fact but may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results in preparing this publication. Smallcaps Daily has relied upon information supplied by its clients, as well as its clients’ publicly available information and press releases which it believes to be reliable; however, such reliability can not be guaranteed. Investors should not rely on the information contained on this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Smallcaps Daily and its owners, affiliates, subsidiaries, officers, directors, representatives, and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of material facts from such advertisement. Smallcaps Daily is not responsible for any claims made by the companies advertised herein, nor is Smallcaps Daily responsible for any other promotional firm, its program, or its structure. Smallcaps Daily is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission, or FINRA. 


    Copyright © 2023 Smallcaps Daily. All rights reserved.

      Thanks for subscribing!
      Check your email for a confirmation message.